Drug Profile
WCK 1152
Alternative Names: WCK 1152ALatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Wockhardt
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action DNA topoisomerase inhibitors; Membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory tract infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Respiratory-tract-infections in India (IV)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Respiratory-tract-infections in India (PO)
- 01 Nov 2006 Phase-I clinical trials in Respiratory tract infections in India (IV)